330 related articles for article (PubMed ID: 37108218)
1. Emerging Non-Antibiotic Options Targeting Uropathogenic Mechanisms for Recurrent Uncomplicated Urinary Tract Infection.
Chen YC; Lee WC; Chuang YC
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108218
[TBL] [Abstract][Full Text] [Related]
2. Urinary Tract Infections Caused by Uropathogenic
Zhou Y; Zhou Z; Zheng L; Gong Z; Li Y; Jin Y; Huang Y; Chi M
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445714
[TBL] [Abstract][Full Text] [Related]
3. VesiX cetylpyridinium chloride is rapidly bactericidal and reduces uropathogenic
Sawant NV; Chang SS; Pandit KA; Khekare P; Warner WR; Zimmern PE; De Nisco NJ
Microbiol Spectr; 2024 Mar; 12(3):e0271223. PubMed ID: 38240572
[TBL] [Abstract][Full Text] [Related]
4. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
Ejrnæs K
Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
[TBL] [Abstract][Full Text] [Related]
5. Urinary tract infections: Can we prevent uropathogenic
Scribano D; Sarshar M; Fettucciari L; Ambrosi C
Int J Vitam Nutr Res; 2021 Sep; 91(5-6):391-395. PubMed ID: 33880966
[No Abstract] [Full Text] [Related]
6. Developments in Mannose-Based Treatments for Uropathogenic Escherichia coli-Induced Urinary Tract Infections.
Hatton NE; Baumann CG; Fascione MA
Chembiochem; 2021 Feb; 22(4):613-629. PubMed ID: 32876368
[TBL] [Abstract][Full Text] [Related]
7. Oral supplementation of trans-cinnamaldehyde reduces uropathogenic Escherichia coli colonization in a mouse model.
Narayanan A; Muyyarikkandy MS; Mooyottu S; Venkitanarayanan K; Amalaradjou MA
Lett Appl Microbiol; 2017 Mar; 64(3):192-197. PubMed ID: 28063174
[TBL] [Abstract][Full Text] [Related]
8. Secondary provoked vestibulodynia in sexually active women with uncomplicated recurrent urinary tract infections.
Salonia A; Clementi MC; Graziottin A; Nappi RE; Castiglione F; Ferrari M; Capitanio U; Damiano R; Montorsi F
J Sex Med; 2013 Sep; 10(9):2265-73. PubMed ID: 23875698
[TBL] [Abstract][Full Text] [Related]
9. Role of D-mannose in urinary tract infections - a narrative review.
Ala-Jaakkola R; Laitila A; Ouwehand AC; Lehtoranta L
Nutr J; 2022 Mar; 21(1):18. PubMed ID: 35313893
[TBL] [Abstract][Full Text] [Related]
10. Reaching the End of the Line: Urinary Tract Infections.
Tamadonfar KO; Omattage NS; Spaulding CN; Hultgren SJ
Microbiol Spectr; 2019 May; 7(3):. PubMed ID: 31172909
[TBL] [Abstract][Full Text] [Related]
11. Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli.
Asadi Karam MR; Habibi M; Bouzari S
Mol Immunol; 2019 Apr; 108():56-67. PubMed ID: 30784763
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic Resistance Among Uropathogenic
Kot B
Pol J Microbiol; 2019 Dec; 68(4):403-415. PubMed ID: 31880885
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection.
Walters MS; Lane MC; Vigil PD; Smith SN; Walk ST; Mobley HL
mBio; 2012; 3(1):. PubMed ID: 22318320
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.
Conover MS; Hadjifrangiskou M; Palermo JJ; Hibbing ME; Dodson KW; Hultgren SJ
mBio; 2016 Apr; 7(2):e00104-16. PubMed ID: 27073089
[TBL] [Abstract][Full Text] [Related]
15. Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment.
Zulk JJ; Clark JR; Ottinger S; Ballard MB; Mejia ME; Mercado-Evans V; Heckmann ER; Sanchez BC; Trautner BW; Maresso AW; Patras KA
mSphere; 2022 Aug; 7(4):e0034522. PubMed ID: 35920561
[TBL] [Abstract][Full Text] [Related]
16. A non-canonical autophagy-dependent role of the ATG16L1
Wang C; Bauckman KA; Ross ASB; Symington JW; Ligon MM; Scholtes G; Kumar A; Chang HW; Twentyman J; Fashemi BE; Xavier RJ; Mysorekar IU
Autophagy; 2019 Mar; 15(3):527-542. PubMed ID: 30335568
[TBL] [Abstract][Full Text] [Related]
17. Rapid Growth of Uropathogenic
Forsyth VS; Armbruster CE; Smith SN; Pirani A; Springman AC; Walters MS; Nielubowicz GR; Himpsl SD; Snitkin ES; Mobley HLT
mBio; 2018 Mar; 9(2):. PubMed ID: 29511075
[TBL] [Abstract][Full Text] [Related]
18. Peptidoglycan Sensing Prevents Quiescence and Promotes Quorum-Independent Colony Growth of Uropathogenic Escherichia coli.
DiBiasio EC; Ranson HJ; Johnson JR; Rowley DC; Cohen PS; Camberg JL
J Bacteriol; 2020 Sep; 202(20):. PubMed ID: 32778561
[TBL] [Abstract][Full Text] [Related]
19. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.
Lee JH; Subhadra B; Son YJ; Kim DH; Park HS; Kim JM; Koo SH; Oh MH; Kim HJ; Choi CH
Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection.
Habibi M; Asadi Karam MR; Bouzari S
Microb Pathog; 2017 Sep; 110():477-483. PubMed ID: 28754265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
